Multaq Drug Injury Attorney Greg Jones
The FDA cleared the drug Multaq (also known as dronedarone) for sale in 2009. Since its approval, Sanofi-Aventis has received multiple complaints of liver function test abnormalities and hepatocellular liver injury in patients.